| The affected eyes | The healthy eyes | P (Paired-t) |
---|---|---|---|
Axial length, mm | 23.92 ± 0.75 | 24.11 ± 1.21 | 0.372 |
logMAR BCVA at presentation, Snellen equivalent | 0.25 ± 0.18 20/36 | 0.07 ± 0.10 20/23 | 0.001 |
IOP at presentation, mmHg | 12.5 ± 2.6 | 13.8 ± 2.8 | 0.010 |
logMAR BCVA at follow up, Snellen equivalent | 0.17 ± 0.23 20/30 | 0.06 ± 0.09 20/23 | 0.020 |
IOP at follow up | 16.5 ± 3.2 | 15.1 ± 2.0 | 0.103 |
Ocular perfusion pressure at follow up, mmHg | 49.20 ± 6.41 | 50.61 ± 6.31 | 0.103 |
FAZ, mm2 | 0.304 ± 0.179 | 0.315 ± 0.111 | 0.693 |
Parafoveal VD of SVC (%) | 44.13 ± 4.90 | 43.17 ± 4.30 | 0.578 |
Parafoveal VD of DVC (%) | 50.24 ± 4.34 | 52.59 ± 4.36 | 0.120 |
Full retinal thickness, μm | 319.13 ± 23.23 | 313.19 ± 11.17 | 0.294 |
Inner retinal thickness, μm | 121.75 ± 15.97 | 122.06 ± 7.52 | 0.943 |
Outer retinal thickness, μm | 195.44 ± 13.47 | 190.81 ± 8.26 | 0.075 |